TipRanks
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
US Market
CAMP
CAMP4 Therapeutics Corporation
RESEARCH TOOLSreports
Want to see CAMP full AI Analyst Report?

CAMP4 Therapeutics Corporation (CAMP) Stock News & Sentiment

141 Followers
Buy Rating Reaffirmed on CAMP4 as ASCEND Trial Strategy and Pipeline Catalysts Support Long-Term Value; Price Target Maintained at $8
Premium
Ratings
Buy Rating Reaffirmed on CAMP4 as ASCEND Trial Strategy and Pipeline Catalysts Support Long-Term Value; Price Target Maintained at $8
1M ago
CAMP
CAMP4 Details ASCEND Trial Plans in SYNGAP1 Disorder
Premium
Company Announcements
CAMP4 Details ASCEND Trial Plans in SYNGAP1 Disorder
1M ago
8K
CAMP
CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating
Premium
Ratings
CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating
3M ago
CAMP
CAMP Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CAMP Upcoming Earnings Report: What to Expect?
3M ago
CAMP
CAMP4 Therapeutics Secures $50 Million Private Financing
Premium
Company Announcements
CAMP4 Therapeutics Secures $50 Million Private Financing
3M ago
8K
CAMP
CAMP4 gains Australian clearance, enabling CMP-002 trial and financing
Premium
Company Announcements
CAMP4 gains Australian clearance, enabling CMP-002 trial and financing
3M ago
8K
CAMP
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
Premium
Company Announcements
CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan
5M ago
8K
CAMP
More CAMP News >

CAMP News on the Web

Piper Sandler Sticks to Its Buy Rating for CAMP4 Therapeutics Corporation (CAMP)
TipRanks News
Bullish
Analysts Are Bullish on Top NA Stocks: Meta Platforms (META), FedEx Freight Holding Company (FDXF)
TipRanks News
Bullish
CFO’s Bold Stock Move Sparks Fresh Buzz Around CAMP4 Therapeutics
TipRanks News
Neutral
Major Insider Move at CAMP4 Therapeutics Raises Investor Eyebrows
TipRanks News
Neutral
Major Insider Move at CAMP4 Therapeutics Shakes Up Investor Buzz
TipRanks News
Neutral
Camp4 Therapeutics (CAMP) Chief Scientific Officer Daniel Tardiff Sells 1,738 Shares, Reducing ...
GuruFocus News
Bearish
CAMP4 Analyst Day, Strong Cash Runway and SYNGAP1 Trial Progress Drive Upward Price-Target Revision to $8 with Buy Rating
TipRanks News
Bullish
Analysts’ Top NA Picks: CAMP4 Therapeutics Corporation (CAMP), Wayfair (W)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CAMP
Sector Average
Media Buzz
This Week2 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CAMP’s Media Buzz Sentiment?
2 articles about CAMP were published this week. In an average week, 3 articles are published.
    What is CAMP’s weekly average amount of articles?
    In an average week, 3 articles about CAMP are published.
      What is CAMP’s News Sentiment?
      100% of articles about CAMP were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week